lilly pharmacy tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity FDA approves Eli Lilly's tirzepatide

GLP-1 drugs are often hailed as miracle treatmentstackling not just diabetes and obesity, but also conditions like heart disease, infertility, and even sleep apnea

While many on the medications said they have changed their lives for the better, some experts are concerned about the long-term effects of these relatively new drugs. Once its approved on the market, theyll collect data for like, a year, and thats it, said Alexis Moore, assistant professor of Physician Assistant studies and a clinician by training

However, this also means that payers will implement cost controls

More tirzepatide users hit 10%, 15%, 20%, and 25% weight loss targets

CookUnity #culinarynutrition #GLP1 #mealdelivery #chefdesigned #nutritionistapproved

The once-daily pill uses drug delivery technology the company acquired in 2020